Cleistanthin B causes G1 arrest and induces apoptosis in mammalian cells

Apoptosis

Volumn 3, Issue 6, 1998, Pages 413-419

  Pradheep Kumar, C P ^a   Pande, G ^b   Shanmugam, G ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Apoptosis; Cell cycle; Cleistanthin B; Etoposide

Indexed keywords

CLEISTANTHUS; CLEISTANTHUS COLLINUS; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 0342749057     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009658518998     Document Type: Article

References (17)

1. Pradheep Kumar CP, Panneerselvam N, Rajesh S, Shanmugam G. Cytotoxic and genotoxic effects of cleistanthin B in normal and tumour cells. Mutagenesis 1996; 11: 543-547.
2. Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, Mehrota BN. Screening of Indian plants for biological activity part II. Indian Exp Bio 1969; 7: 20.
3. Pradheepkumar CP. Regulation of cell proliferation: effects of cleistanthins on the proliferation of normal and tumour cells. Ph D Thesis. Madurai Kamaraj University: 1998.
4. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implication in disease kinetics. Br J Cancer 1972; 26: 239-257.
5. Sen S, D'Incalci M. Apoptosis: Biological events and relevance to cancer chemotherapy. FEBS Lett 1992; 307: 122-127.
6. Fawthrop DJ, Boobis AR, Davies DS. Mechanisms of cell death. Arch Toxicol 1991; 65: 437-444.
7. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (Apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 40: 2353-2362.
8. Ormerod MG, Orr RM, Peacock JH. The role of apoptosis in cell killing by cisplatin: a flow cytometric study. Br J Cancer 1994; 69: 93-100.
9. Kastan MB, Zhan Q, El-Diery WS, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587-597.
10. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking P21. Nature 1996; 381: 713-716.
11. Nasmyth K, Hunt T. Dams and sluice. Nature 1994; 366: 634-635.
12. Meikrantz W, Gisselbrecht S, Tarn SW, Schlegel R. Activation of cyclin-A dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 1994; 91: 3754-3758.
13. Kondo S. Apoptosis by antitumor agents and other factors in relation to cell cycle checkpoints. J Radiat Res 1995; 36: 56-62.
14. Afanas'ev VN, Korol' BA, Mantsygin YA, Nelipovich PA, Pechtnikov VA, Umansky SR. Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death. FEBS Lett 1986; 194: 347-350.
15. Frankfurt OS, Byrnes JJ, Seckinge D, Sugarbaker EV. Apoptosis (programmed cell death) and the evaluation of chemosensitivity in chronic lymphocytic leukaemia and lymphoma. Oncology Res 1993; 5: 37-42.
16. Wrasidlo W, Johnson DS, Boger DL. Induction of endonucleolytic DNA fragmentation and apoptosis by the Duocarmycins. Bioorg Medicn Chem Letters 1994; 4: 631-636.
17. Nicolaou KC, Dai WM, Tsay SC, Estevez VA, Wrasidlo W. Designed enediynes: a new class of DNA-cleaving molecules with potent and selective anticancer activity. Science 1992; 256: 1172-1178.